Drug Type Diagnostic radiopharmaceuticals, Fluorophore-conjugated therapeutics |
Synonyms AS1986NS |
Target |
Action modulators |
Mechanism PSMA modulators(Prostate-specific membrane antigen modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Adenocarcinoma of prostate | Phase 2 | United States | 01 Jun 2025 | |
Adenocarcinoma of prostate | Phase 2 | Taiwan Province | 01 Jun 2025 |